Nippon India Pharma Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Invest NowNippon India Pharma Fund-Growth Plan-Growth Option
Invest NowChart Comparison
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹828 Cr | ₹7404 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 05 Oct 2023 | 01 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.29 | 1.82 |
Manager | Dhruv Muchhal | Sailesh Raj Bhan |
ISIN Code | INF179KC1HL7 | INF204K01968 |
Exits Load | Exit load of 1%, if redeemed within 30 days./365 | Exit load of 1% if redeemed within 1 month./365 |
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 8.61% | 6.25% |
6 Month | 25.31% | 19.11% |
1 Year | - | 47.43% |
3 Year | - | 18.54% |
5 Year | - | 30.13% |
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | - | - |
1 Year | 12.24% | 17.1% |
3 Year | 12.24% | 43.51% |
5 Year | 12.24% | 81.66% |
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 12.72% | 26.16% |
3 Year | 12.72% | 53.8% |
5 Year | 12.72% | 80.65% |
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | - | 14.36% |
Sharp | - | 0.68% |
Beta | - | 0.91% |
Alpha | - | 1.57% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts GuidanceScheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Dhruv Muchhal | Sailesh Raj Bhan |
Total AUM | ₹520687 Cr | ₹96086 Cr |
Fund Manage | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.98 | 1.66 |
Small Cap | 33.12 | 20.97 |
Large Cap | 32.5 | 41.85 |
Mid Cap | 32.4 | 35.52 |
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.98 | 1.66 |
Pharmaceuticals & Biotechnology | 74.71 | - |
Healthcare Services | 22.28 | - |
Retailing | 1.03 | - |
Healthcare | - | 98.34 |
Top Comparisons
Nippon India Strategic Debt Fund - Growth Option
3Y Returns5.14%
Invesco India Medium Duration Fund - Regular - Growth
3Y Returns4.74%
Bajaj Finserv Flexi Cap Fund Regular - Growth
3Y Returns0%
Edelweiss Flexi Cap Fund - Regular Plan - Growth Option
3Y Returns21.46%
BANDHAN Core Equity Fund - Regular Plan - Growth
3Y Returns27.55%
Nippon India Vision Fund-Growth Plan-Growth Option
3Y Returns22.69%
BANDHAN Large Cap Fund - Regular Plan - Growth
3Y Returns17.66%
Invesco India Largecap Fund - Growth
3Y Returns16.76%